Drug discovery startup Congruence Therapeutics closes $20 million CAD extension of Series A
BDC Capital's Thrive Venture Fund joined to lead the extension. Congruence Therapeutics has secured an additional $20 million CAD ($15 ...
© Business News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.